BankPlus Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BankPlus Wealth Management's BMY Position: Q3 2026 in Review
BankPlus Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q3 2026, selling an estimated $8.53K and leaving 7,123 shares worth $445K. The position accounts for 0.19% of the portfolio, ranked #76.
BankPlus Wealth Management first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $577K in Q1 2025. 2,541 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- BankPlus Wealth Management held 7,123 shares of Bristol-Myers Squibb worth $445K as of Q3 2026.
- BankPlus Wealth Management sold 135 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.53K.
- Bristol-Myers Squibb made up 0.19% of BankPlus Wealth Management's portfolio in Q3 2026, its #76 holding.
- BankPlus Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- BankPlus Wealth Management's Bristol-Myers Squibb position peaked at $577K in Q1 2025.
- 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.